Fig. 2From: Early tirofiban versus heparin for bridging dual antiplatelet therapy in patients undergoing coronary endarterectomy combined with coronary artery bypass grafting: a multicenter randomized controlled trial protocol (the THACE-CABG trial)Timeline of antithrombotic drugs. DAPT, dual antiplatelet therapiesBack to article page